Masafumi Koshiyama

Dr. Masafumi Koshiyama

Department of Women’s Health, Graduate School of Human Nursing, The University of Shiga Prefecture
orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2017 in Diagnostics
Verified
Journal Article
Open access
PDF file
Masafumi KoshiyamaMasafumi Koshiyama
Masafumi Koshiyama
Noriomi MatsumuraNoriomi Matsumura
Noriomi Matsumura
IKIkuo Konishi
Ikuo Konishi
Ovarian cancer is the foremost cause of gynecological cancer death in the developed world, as it is usually diagnosed at an advanced stage. In this paper we discuss current issues, the efficacy and problems associated with ovarian cancer screening, and compare the characteristics of ovarian cancer subtypes. There are two types of ovarian cancer: Type I carcinomas, which are slow-growing, indolent neoplasms thought to arise from a precursor lesion, which are relatively common in Asia; and Type II carcinomas, which are clinically aggressive neoplasms that can develop de novo from serous tubal intraepithelial carcinomas (STIC) and/or ovarian surface epithelium and are common in Europe and the USA. One of the most famous studies on the subject reported that annual screening using CA125/transvaginal sonography (TVS) did not reduce the ovarian cancer mortality rate in the USA. In contrast, a recent study in the UK showed an overall average mortality reduction of 20% in the screening group. Another two studies further reported that the screening was associated with decreased stage at detection. Theoretically, annual screening using CA125/TVS could easily detect precursor lesions and could be more effective in Asia than in Europe and the USA. The detection of Type II ovarian carcinoma at an early stage remains an unresolved issue. The resolving power of CA125 or TVS screening alone is unlikely to be successful at resolving STICs. Biomarkers for the early detection of Type II carcinomas such as STICs need to be developed.

7 July 2019 in Healthcare
Verified
Journal Article
Open access
Masafumi KoshiyamaMasafumi Koshiyama
Masafumi Koshiyama
The contribution of diet to cancer risk has been considered to be higher in advanced countries than in developing countries. In this paper, I review the current issues (a review of the relevant literature), and the effects of the dietary and nutrient intake on three types of gynecologic cancer (cervical, endometrial and ovarian cancers). In cervical cancer, the most important roles of diet/nutrition in relation to cancer are prophylaxis and countermeasures against human papillomavirus (HPV) infection. The main preventive and reductive factors of cervical cancer are antioxidants, such as vitamin A, C, D and E, carotenoids, vegetables and fruits. These antioxidants may have different abilities to intervene in the natural history of diseases associated with HPV infection. For endometrial cancer, the increase in peripheral estrogens as a result of the aromatization of androgens to estrogens in adipose tissue in obese women and insulin resistance are risk factors. Thus, we must mainly take care to avoid the continuous intake of fat energy and sugar. In ovarian cancer, the etiology has not been fully understood. To the best of our knowledge, the long-term consumption of pro-inflammatory foods, including saturated fat, carbohydrates and animal proteins is a risk factor. The intake of acrylamide is also a risk factor for both endometrial and ovarian cancer. Most papers have been epidemiological studies. Thus, further research using in vitro and in vivo approaches is needed to clarify the effects of the dietary and nutrient intake in detail.

11 September 2011 in Obstetrics and Gynecology International
Verified
Journal Article
Open access
PDF file
YYYukio Yamanishi
Yukio Yamanishi
Masafumi KoshiyamaMasafumi Koshiyama
Masafumi Koshiyama
MOMegumi Ohnaka
Megumi Ohnaka
MUMasashi Ueda
Masashi Ueda
SUShingo Ukita
Shingo Ukita
TSTomoyuki Shirase
Tomoyuki Shirase
To investigate the metastatic pathways from the primary organs to the ovaries, we examined the microscopic findings from 18 original and 18 metastatic ovarian tumors carefully. In addition, we examined the immunohistochemical findings (Victoria blue stain for vascular invasion and D2-40 expression for lymphangio invasion) of metastatic ovarian tumors carefully. There were 4 (57%) ovarian lymphangio invasion cases in the 7 gastric cancers, but there were no cases in the 6 colorectal cancers (P< 0.05). There were 4 (67%) ovarian vascular invasion cases and one (17%) liver metastasis case in the 6 colorectal cancers, while there were no ovarian vascular invasions (P< 0.05) or no liver metastases in the 7 gastric cancers. The patients with metastatic ovarian tumors originating from distant organs who were treated at the same time as the original cancers had a significantly poorer prognosis than the patients with ovarian tumors treated later (P< 0.05). The rate of lymphatic metastasis from the stomach to the ovary was significantly higher than from the colon to the ovary. In addition we hypothesized that the rate of intravascular metastasis from the colorectum to the ovary was relatively higher than from the stomach to the ovary.

10 November 2020 in Medicina
Verified
Journal Article
Open access
PDF file
AOAyumi Ono
Ayumi Ono
Masafumi KoshiyamaMasafumi Koshiyama
Masafumi Koshiyama
MNMiwa Nakagawa
Miwa Nakagawa
YWYumiko Watanabe
Yumiko Watanabe
EIEri Ikuta
Eri Ikuta
MOMakiko Oowaki
Makiko Oowaki
Cervical cancer results from a continuous process, starting from a normal cervical epithelium after human papillomavirus (HPV) infection and progressing to cervical intraepithelial neoplasia (CIN), before finally developing into invasive squamous carcinoma (ISC). In recent decades, dietary antioxidants, such as vitamins, have received much attention in relation to cancer prevention. We reviewed the relevant literature to investigate the dietary and nutrient intake on cervical cancer. The intake of vitamins A and D and carotenoids may inhibit early cervical cancer development. The intake of folate may prevent or inhibit HPV infection rom progressing to various grades of CIN. The intake of vitamins C and E may widely inhibit the process of cervical cancer development. Polyphenols are often used in cases of cervical cancer in combination chemotherapy and radiation therapy. Regarding nutrients, different antioxidants may have differing abilities to intervene in the natural history of cervical diseases associated with HPV infection. Regarding foods, the intake of both vegetables and fruits containing multiple vitamins may widely suppress cervical cancer development. Most previous papers have described epidemiological studies. Thus, further research using in vitro and in vivo approaches will be needed to clarify the effects of the dietary and nutrient intake in detail.

1 April 2016 in Gynecologic Oncology
Verified
Journal Article
Closed access
RMRyusuke Murakami
Ryusuke Murakami
Noriomi MatsumuraNoriomi Matsumura
Noriomi Matsumura
JBJ.B. Brown
J.B. Brown
ZWZhipeng Wang
Zhipeng Wang
KYKen Yamaguchi
Ken Yamaguchi
IKIkuo Konishi
Ikuo Konishi

1 July 2009 in Rare Tumors
Verified
Journal Article
Open access
PDF file
SUShingo Ukita
Shingo Ukita
Masafumi KoshiyamaMasafumi Koshiyama
Masafumi Koshiyama
MOMegumi Ohnaka
Megumi Ohnaka
NMNaoyuki Miyagawa
Naoyuki Miyagawa
YYYukio Yamanishi
Yukio Yamanishi
HOHiroshi Ozasa
Hiroshi Ozasa
Retroperitoneal benign lipomas are extremely rare and represent about 2.9% of all primary retroperitoneal tumors. About 80% of the tumors in the retroperitoneal cavities are malignant neoplasms. We experienced a case of a retroperitoneal lipoma simulating an ovarian mature cystic teratoma. A diagnosis was correctly made by magnetic resonance imaging (MRI) prior to surgery, and a total tumorectomy was performed. The retroperitoneal lipoma was recognized to have arisen from the urinary bladder. Histological sections revealed a tumor consisting of typical adipose cells without atypia. These types of lipomas should be carefully followed-up because they often recur and undergo malignant transformations.